U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H23F4N3O
Molecular Weight 385.399
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMS-986176

SMILES

CC(C)C[C@](C)(N)COC1=CC=C(N=C1C(F)F)C2=CC=NC(=C2)C(F)F

InChI

InChIKey=RKAHOQATMSONTM-IBGZPJMESA-N
InChI=1S/C19H23F4N3O/c1-11(2)9-19(3,24)10-27-15-5-4-13(26-16(15)18(22)23)12-6-7-25-14(8-12)17(20)21/h4-8,11,17-18H,9-10,24H2,1-3H3/t19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H23F4N3O
Molecular Weight 385.399
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:06:48 GMT 2023
Edited
by admin
on Sat Dec 16 18:06:48 GMT 2023
Record UNII
9G4RLM5X6Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BMS-986176
Code English
LX-9211
Code English
2-PENTANAMINE, 1-((2',6-BIS(DIFLUOROMETHYL)(2,4'-BIPYRIDIN)-5-YL)OXY)-2,4-DIMETHYL-, (2S)-
Systematic Name English
AAK1-IN-1
Common Name English
(2S)-1-((2',6-BIS(DIFLUOROMETHYL)(2,4'-BIPYRIDIN)-5-YL)OXY)-2,4-DIMETHYL-2-PENTANAMINE
Systematic Name English
Code System Code Type Description
SMS_ID
300000028091
Created by admin on Sat Dec 16 18:06:48 GMT 2023 , Edited by admin on Sat Dec 16 18:06:48 GMT 2023
PRIMARY
PUBCHEM
118419773
Created by admin on Sat Dec 16 18:06:48 GMT 2023 , Edited by admin on Sat Dec 16 18:06:48 GMT 2023
PRIMARY
CAS
1815613-42-3
Created by admin on Sat Dec 16 18:06:48 GMT 2023 , Edited by admin on Sat Dec 16 18:06:48 GMT 2023
PRIMARY
FDA UNII
9G4RLM5X6Z
Created by admin on Sat Dec 16 18:06:48 GMT 2023 , Edited by admin on Sat Dec 16 18:06:48 GMT 2023
PRIMARY
Related Record Type Details
BINDER->LIGAND
BINDING
TARGET -> INHIBITOR
ENZYMATIC ASSAY
IC50
TARGET -> INHIBITOR
CELL ASSAY
IC50
TARGET -> INHIBITOR
Ki
Name Property Type Amount Referenced Substance Defining Parameters References
BRAIN/PLASMA RATIO PHARMACOKINETIC RAT STUDY
PHARMACOKINETIC